An Analysis of Medicare Reimbursement to Ophthalmologists: Years 2012 to 2013
Authors:
- 1 October 2017
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 182, 133-140
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Physician Utilization Patterns for VEGF-Inhibitor Drugs in the 2012 United States Medicare Population: Bevacizumab, Ranibizumab, and AfliberceptOphthalmic Surgery, Lasers and Imaging Retina, 2016
- Neovascular Age-Related Macular Degeneration2015
- Advances in pharmacotherapy for wet age-related macular degenerationExpert Opinion on Pharmacotherapy, 2015
- Treating Age-Related Macular Degeneration: Comparing The Use Of Two Drugs Among Medicare And Veterans Affairs PopulationsHealth Affairs, 2015
- Anti-VEGF Therapy for Diabetic Macular EdemaCurrent Diabetes Reports, 2014
- The Effects of Technological Advances on Outcomes for Elderly Persons With Exudative Age-related Macular DegenerationJAMA Ophthalmology, 2014
- Longitudinal Incidence of Adverse Outcomes of Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2009
- The Economic Burden of Major Adult Visual Disorders in the United StatesArchives of Ophthalmology (1950), 2006
- Effect of Depression on Vision Function in Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2002
- Depression, visual acuity, comorbidity, and disability associated with age-related macular degenerationOphthalmology, 2001